- Home
- AXSM vs SKT Comparison
AXSM vs SKT Comparison
Compare AXSM & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- SKT
- Stock Information
- Founded
- AXSM 2012
- SKT 1981
- Country
- AXSM United States
- SKT United States
- Employees
- AXSM N/A
- SKT N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- SKT Real Estate Investment Trusts
- Sector
- AXSM Health Care
- SKT Real Estate
- Exchange
- AXSM Nasdaq
- SKT Nasdaq
- Market Cap
- AXSM 4.2B
- SKT 3.8B
- IPO Year
- AXSM 2015
- SKT 1993
- Fundamental
- Price
- AXSM $137.75
- SKT $35.82
- Analyst Decision
- AXSM Strong Buy
- SKT Buy
- Analyst Count
- AXSM 14
- SKT 9
- Target Price
- AXSM $158.93
- SKT $35.11
- AVG Volume (30 Days)
- AXSM 1.1M
- SKT 722.0K
- Earning Date
- AXSM 02-18-2025
- SKT 02-19-2025
- Dividend Yield
- AXSM N/A
- SKT 3.06%
- EPS Growth
- AXSM N/A
- SKT N/A
- EPS
- AXSM N/A
- SKT 0.88
- Revenue
- AXSM $385,693,000.00
- SKT $537,352,000.00
- Revenue This Year
- AXSM $45.18
- SKT N/A
- Revenue Next Year
- AXSM $65.22
- SKT $3.99
- P/E Ratio
- AXSM N/A
- SKT $40.82
- Revenue Growth
- AXSM 42.53
- SKT 13.69
- 52 Week Low
- AXSM $64.11
- SKT $25.94
- 52 Week High
- AXSM $139.13
- SKT $37.57
- Technical
- Relative Strength Index (RSI)
- AXSM 74.55
- SKT 66.01
- Support Level
- AXSM $124.04
- SKT $34.17
- Resistance Level
- AXSM $130.52
- SKT $36.76
- Average True Range (ATR)
- AXSM 5.78
- SKT 0.85
- MACD
- AXSM 1.11
- SKT 0.30
- Stochastic Oscillator
- AXSM 96.07
- SKT 78.49
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About SKT Tanger Inc.
Tanger Inc is a leading owner and operator of outlet and open-air retail shopping destinations. Tanger's portfolio of 38 outlet centers and one open-air lifestyle center comprises over 15 million square feet well positioned across tourist destinations and vibrant markets in U.S. states and Canada.